Company facts
- Headquarters
- South San Francisco, California
- Most recent report
- 10-Q, filed Nov 5, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 72444
- Fiscal year ends
- December
- Filer status
- Accelerated filer, Smaller reporting company
Financials 8 of 66
News 8 of 291
Prospectuses and Registrations 8 of 54
- 424B3 Prospectus supplement for an offering May 19, 2026
- S-1/A Registration statement for an offering, amended May 18, 2026
- S-1 Registration statement for an offering May 8, 2026
- 424B5 Prospectus supplement for an offering May 4, 2026
- S-3 Shelf registration statement Apr 16, 2026
- 25-NSE Notice that a security was delisted Nov 21, 2025
- 424B5 Prospectus supplement for an offering Nov 5, 2025
- 424B5 Prospectus supplement for an offering Mar 21, 2025
Proxies 8 of 102
- DEFA14A Extra proxy material Jul 6, 2026
- DEFA14A Extra proxy material Jul 2, 2026
- DEFA14A Extra proxy material Jul 1, 2026
- DEFA14A Extra proxy material Jun 26, 2026
- DEFA14A Extra proxy material Jun 26, 2026
- DEFA14A Extra proxy material Jun 26, 2026
- DEFA14A Extra proxy material Jun 26, 2026
- DEFA14A Extra proxy material Jun 16, 2026
Ownership 8 of 379
- 4 Insider reported a trade Oct 20, 2026
- 3 Insider reported their initial holding Oct 20, 2026
- 4 Insider reported a trade Jul 20, 2026
- 4 Insider reported a trade Jul 17, 2026
- 4 Insider reported a trade Jul 17, 2026
- 4 Insider reported a trade Jul 17, 2026
- 4 Insider reported a trade Jul 17, 2026
- 4 Insider reported a trade May 26, 2026
Other 8 of 108
Everything here comes from Vaxart, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.